Wren laboratories announces advanced NETest 2.0 for neuroendocrine tumour diagnostics
Wren Laboratories has officially discontinued their original NETest 1.0 in favour of an AI-enhanced successor. The new liquid biopsy diagnostic offers improved sensitivity and accuracy for monitoring neuroendocrine tumours through an optimised 51-gene mRNA expression algorithm.